Mainolfi Nello sold KYMR
February 25, 2026 · Form 4 insider transaction
Mainolfi Nello sold 8 shares of Kymera Therapeutics, Inc. at $93.49 per share, a transaction worth $747.92. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
8
Price
$93.49
Total value
$747.92
InsiderMainolfi Nello
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2026
Filing dateFebruary 25, 2026
Shares owned after666,195
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.